Frontiers in Pharmacology (Feb 2023)

The role of antenatal corticosteroids in twin pregnancy

  • Jie Zhu,
  • Jie Zhu,
  • Shuyue Li,
  • Shuyue Li,
  • Ying Zhao,
  • Ying Zhao,
  • Yu Xiong,
  • Yu Xiong

DOI
https://doi.org/10.3389/fphar.2023.1072578
Journal volume & issue
Vol. 14

Abstract

Read online

Twin pregnancy was associated with significantly higher rates of adverse neonatal and perinatal outcomes. One of the underlying causes is that twins are prone to preterm birth. Antenatal corticosteroids are widely used for reducing the incidence of neonatal respiratory distress syndrome initially and other neonatal mortality and morbidities subsequently. As it is widely used as a prophylactic treatment for potential premature births, there remain controversies of issues relating to twin gestations, including window for opportunity, timing of use, repeat course, optimal administration-to-delivery intervals, dosage, and type of corticosteroid. Thus, we present a thorough review of antenatal corticosteroids usage in twin gestation, emphasizing the aforementioned issues and attempting to offer direction for future investigation and clinical practice.

Keywords